Education
Ph.D. in molecular biology (Immunology), Osaka University, Japan
Current position
Assistant Professor, Immune Regulation, Immunology Frontier Research Center (IFReC), Osaka University, Japan
Publications
-
Tanaka, T., Narazaki, M. and Kishimoto, T. (2016). Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy 8(8): 959-970.
-
Masuda, K. and Kishimoto, T. (2016). CD5: A New Partner for IL-6. Immunity 44(4): 720-722.
-
Masuda, K., Ripley, B., Nyati, K. K., Dubey, P. K., Zaman, M. M., Hanieh, H., Higa, M., Yamashita, K., Standley, D. M., Mashima, T., Katahira, M., Okamoto, T., Matsuura, Y., Takeuchi, O. and Kishimoto, T. (2016). Arid5a regulates naive CD4+ T cell fate through selective stabilization of Stat3 mRNA. J Exp Med 213(4): 605-619.
-
Millrine, D., Miyata, H., Tei, M., Dubey, P., Nyati, K., Nakahama, T., Gemechu, Y., Ripley, B. and Kishimoto, T. (2016). Immunomodulatory drugs inhibit TLR4-induced type-1 interferon production independently of Cereblon via suppression of the TRIF/IRF3 pathway. Int Immunol 28(6): 307-315.
-
Chinen, I., Nakahama, T., Kimura, A., Nguyen, N. T., Takemori, H., Kumagai, A., Kayama, H., Takeda, K., Lee, S., Hanieh, H., Ripley, B., Millrine, D., Dubey, P. K., Nyati, K. K., Fujii-Kuriyama, Y., Chowdhury, K. and Kishimoto, T. (2015). The aryl hydrocarbon receptor/microRNA-212/132 axis in T cells regulates IL-10 production to maintain intestinal homeostasis. Int Immunol 27(8): 405-415.
-
Kishimoto, T. (2015). Introduction: Antibody-targeted therapy special issue. Int Immunol 27(1): 1-2.
-
Nguyen, N. T., Nakahama, T., Nguyen, C. H., Tran, T. T., Le, V. S., Chu, H. H. and Kishimoto, T. (2015). Aryl hydrocarbon receptor antagonism and its role in rheumatoid arthritis. J Exp Pharmacol 7: 29-35.